Case Study: MCRA Assists Australian Company Epiminder with FDA Breakthrough Designation for Epilepsy Monitoring Technology

MCRA’s Neurology team, led by John Doucet, PhD recently worked with Epiminder, an Australian company, to obtain FDA breakthrough designation for their epilepsy monitoring technology. Read about how Dr. Doucet and MCRA’s expert Neurology team played a crucial role in getting this epilepsy medtech to market.

Learn about MCRA's neurology services.